We are live on ! Find out more
INMB icon

INmune Bio
INMB

33 hedge funds and large institutions have $11.7M invested in INmune Bio in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more call options, than puts

Call options by funds: $350K | Put options by funds: $157K

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

0.55% less ownership

Funds ownership: 11.23% → 10.67% (-0.55%)

8% less funds holding

Funds holding: 36 → 33 (-3)

33% less capital invested

Capital invested by funds: $17.4M → $11.7M (-$5.72M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
33
Holders Change
-3
Holders Change %
-8.33%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
8
Closed
6
Calls
$350K
Puts
$157K
Net Calls
+$193K
Net Calls Change
-$39K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$239K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$209K
3
Citadel Advisors
Citadel Advisors
Florida
+$83.1K
4
TRCT
Tower Research Capital (TRC)
New York
+$34.3K
5
Group One Trading
Group One Trading
Illinois
+$23.6K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$696K
2
Renaissance Technologies
Renaissance Technologies
New York
-$284K
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$139K
4
FAIM
Financial Advocates Investment Management
Washington
-$134K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
VNA
26
Valley National Advisers
Pennsylvania
$7K – – –
CCM
27
Covington Capital Management
California
$6K – – –
ADL
28
Asset Dedication LLC
California
$5K – – –
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.48K – – –
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$2.3K +$3.26K +371 New
FIA
31
FNY Investment Advisers
New York
$1K – – –
IA
32
IFP Advisors
Florida
$1K – – –
WIM
33
Westside Investment Management
California
$187 +$878 +100 +0.3%
Renaissance Technologies
34
Renaissance Technologies
New York
– -$284K -32,100 Closed
FAIM
35
Financial Advocates Investment Management
Washington
– -$134K -15,167 Closed
Citigroup
36
Citigroup
New York
– -$11K -1,300 Closed
PNC Financial Services Group
37
PNC Financial Services Group
Pennsylvania
– -$8K -820 Closed
HNWAG
38
High Net Worth Advisory Group
Florida
– -$4K -500 Closed
CAPTRUST Financial Advisors
39
CAPTRUST Financial Advisors
North Carolina
– -$2K -269 Closed
1
2

INMB Hedge Fund Activity: Q3 2022 in Review

33 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q3 2022, worth a combined $11.7M — down 33% from $17.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of INMB and 4 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 9 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $239K. The largest seller was Morgan Stanley, cutting an estimated $696K.

  • 33 institutional investors held INmune Bio (INMB) as of Q3 2022, down from 36 in Q2 2022.
  • Funds reported $11.7M of INmune Bio stock for Q3 2022, down 33% quarter-over-quarter.
  • 4 funds opened new INmune Bio positions in Q3 2022 and 6 closed out, a net change of -2 holders.
  • The largest INmune Bio buyer in Q3 2022 was Millennium Management, an estimated $239K added.
  • The largest INmune Bio seller in Q3 2022 was Morgan Stanley, an estimated $696K sold.

Based on aggregated 13F filings for Q3 2022.